These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38894922)
1. Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2. Nikas SP; Ji L; Liu Y; Georgiadis MO; Dopeshwarkar A; Straiker A; Kudalkar S; Sadybekov AV; Dvorakova M; Katritch V; Mackie K; Marnett L; Makriyannis A ACS Med Chem Lett; 2024 Jun; 15(6):965-971. PubMed ID: 38894922 [TBL] [Abstract][Full Text] [Related]
2. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320 [TBL] [Abstract][Full Text] [Related]
3. 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1. Farah SI; Hilston S; Tran N; Zvonok N; Makriyannis A Biochem Biophys Res Commun; 2022 Feb; 591():31-36. PubMed ID: 34995983 [TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805 [TBL] [Abstract][Full Text] [Related]
5. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain. Thomas A; Okine BN; Finn DP; Masocha W Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895 [TBL] [Abstract][Full Text] [Related]
6. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands. Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418 [TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system in the adipose organ. Jung KM; Lin L; Piomelli D Rev Endocr Metab Disord; 2022 Feb; 23(1):51-60. PubMed ID: 33387286 [TBL] [Abstract][Full Text] [Related]
9. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
10. The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System. Wolfe SA; Vozella V; Roberto M Alcohol Res; 2022; 42(1):03. PubMed ID: 35223337 [TBL] [Abstract][Full Text] [Related]
12. 2-Arachidonoyl glycerol potently induces cholecystokinin secretion in murine enteroendocrine STC-1 cells via cannabinoid receptor CB1. Ochiai K; Hirooka R; Sakaino M; Takeuchi S; Hira T Lipids; 2021 Nov; 56(6):603-611. PubMed ID: 34533218 [TBL] [Abstract][Full Text] [Related]
13. 2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity. Lu L; Williams G; Doherty P Cannabis Cannabinoid Res; 2019; 4(4):231-239. PubMed ID: 31872059 [No Abstract] [Full Text] [Related]
14. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Járai Z; Wagner JA; Goparaju SK; Wang L; Razdan RK; Sugiura T; Zimmer AM; Bonner TI; Zimmer A; Kunos G Hypertension; 2000 Feb; 35(2):679-84. PubMed ID: 10679517 [TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. Fride E Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678 [TBL] [Abstract][Full Text] [Related]
16. Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice. Ahluwalia M; Mcmichael H; Kumar M; Espinosa MP; Bosomtwi A; Lu Y; Khodadadi H; Jarrahi A; Khan MB; Hess DC; Rahimi SY; Vender JR; Vale FL; Braun M; Baban B; Dhandapani KM; Vaibhav K Exp Neurol; 2023 Mar; 361():114320. PubMed ID: 36627040 [TBL] [Abstract][Full Text] [Related]
17. ( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes. Liu Y; Ji L; Eno M; Kudalkar S; Li AL; Schimpgen M; Benchama O; Morales P; Xu S; Hurst D; Wu S; Mohammad KA; Wood JT; Zvonok N; Papahatjis DP; Zhou H; Honrao C; Mackie K; Reggio P; Hohmann AG; Marnett LJ; Makriyannis A; Nikas SP J Med Chem; 2018 Oct; 61(19):8639-8657. PubMed ID: 30196704 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256 [TBL] [Abstract][Full Text] [Related]
19. The Role of Cannabinoids in the Setting of Cirrhosis. Dibba P; Li AA; Cholankeril G; Iqbal U; Gadiparthi C; Khan MA; Kim D; Ahmed A Medicines (Basel); 2018 Jun; 5(2):. PubMed ID: 29890719 [TBL] [Abstract][Full Text] [Related]
20. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]